Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome

Geoffrey Zubay; B. J. Druker; M. Talpaz; D. J. Resta; B. Peng; E. Buchdunger; J. M. Ford; N. B. Lydon; H. Kantarjian; R. Capdeville; S. Ohno-Jones; C. L. Sawyers

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome

Geoffrey Zubay, B. J. Druker, M. Talpaz, D. J. Resta, B. Peng, E. Buchdunger, J. M. Ford, N. B. Lydon, H. Kantarjian, R. Capdeville, S. Ohno-Jones, C. L. Sawyers

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	733-738
Number of pages	6
Journal	Chemtracts
Volume	14
Issue number	13
State	Published - 2001
Externally published	Yes

ASJC Scopus subject areas

Chemistry(all)
Biochemistry
Molecular Biology

Cite this

Zubay, G., Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., & Sawyers, C. L. (2001). Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome. Chemtracts, 14(13), 733-738.

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia : Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome. / Zubay, Geoffrey; Druker, B. J.; Talpaz, M. et al.

In: Chemtracts, Vol. 14, No. 13, 2001, p. 733-738.

Research output: Contribution to journal › Review article › peer-review

Zubay, G, Druker, BJ, Talpaz, M, Resta, DJ, Peng, B, Buchdunger, E, Ford, JM, Lydon, NB, Kantarjian, H, Capdeville, R, Ohno-Jones, S & Sawyers, CL 2001, 'Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome', Chemtracts, vol. 14, no. 13, pp. 733-738.

Zubay G, Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome. Chemtracts. 2001;14(13):733-738.

Zubay, Geoffrey ; Druker, B. J. ; Talpaz, M. et al. / Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia : Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome. In: Chemtracts. 2001 ; Vol. 14, No. 13. pp. 733-738.

@article{a9e0ffed2e6f468eaaa32ba8cac57e48,

title = "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome",

author = "Geoffrey Zubay and Druker, {B. J.} and M. Talpaz and Resta, {D. J.} and B. Peng and E. Buchdunger and Ford, {J. M.} and Lydon, {N. B.} and H. Kantarjian and R. Capdeville and S. Ohno-Jones and Sawyers, {C. L.}",

year = "2001",

language = "English (US)",

volume = "14",

pages = "733--738",

journal = "Chemtracts",

issn = "1431-9268",

publisher = "Data Trace Publishing Co.",

number = "13",

}

TY - JOUR

T1 - Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

T2 - Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome

AU - Zubay, Geoffrey

AU - Druker, B. J.

AU - Talpaz, M.

AU - Resta, D. J.

AU - Peng, B.

AU - Buchdunger, E.

AU - Ford, J. M.

AU - Lydon, N. B.

AU - Kantarjian, H.

AU - Capdeville, R.

AU - Ohno-Jones, S.

AU - Sawyers, C. L.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0035717420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035717420&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0035717420

SN - 1431-9268

VL - 14

SP - 733

EP - 738

JO - Chemtracts

JF - Chemtracts

IS - 13

ER -

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome

ASJC Scopus subject areas

Other files and links

Cite this